Shanghai GenTech Co., Ltd. Class A

Shanghai GenTech Co., Ltd. Class A

SSSE:688596
45.45
CNY
-2.15
(-4.52%)
23.25BMarket Cap
Oct 31Next Earn
Shanghai GenTech Co., Ltd. Class A
SSE:688596
(Shanghai Stock Exchange)

Recent

price

45.45

P/E

ratio

- -

div

yld

0.56%

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.45
3.34
3.29
3.87
4.63
5.83
6.43
5.18
7.2
10.56
14.05
19.48
17.31
- -
Revenue per Share
-0.03
0.11
0.08
0.14
0.2
0.38
0.45
0.58
0.66
1.01
1.47
1.88
0.48
- -
Basic EPS, GAAP
-0.03
0.11
-0.44
-0.35
-0.75
0.57
0.24
-0.4
-0.81
-1.65
-0.9
-0.09
-0.6
- -
Free Cash Flow per Basic Share
- -
0.01
0.02
0.01
0.03
0.15
0.06
0.03
0.1
0.18
0.09
0.38
0.39
0.25
Dividend per Share
1.84
1.47
1.99
2.15
2.38
2.88
3.48
6.65
7.27
8.8
10.7
11.89
12.8
11.68
Book Value per Share
1.6
1.24
1.75
1.92
2.15
2.67
3.3
6.51
6.99
8.25
10.05
10.73
7.33
6.28
Tangible Book Value per Share
149
149
156
150
153
158
184
214
255
256
273
281
284
287
Basic Weighted Avg Shares
216
498
512
580
707
921
1,186
1,109
1,837
2,705
3,835
5,469
4,916
- -
Sales/Revenue/Turnover
-6.29
4.85
5.12
4.71
7.06
11.34
10.11
11.14
10.1
10.65
12.13
13.53
6.59
- -
Operating Margin (%)
9
7
13
15
15
18
28
33
44
55
76
106
178
- -
Depreciation Expense
-4
16
12
21
31
60
83
124
168
259
401
528
136
- -
Net Income, GAAP
- -
18.33
12.06
18.89
13.24
12.8
11.05
13.02
8.3
2.51
3.89
3.53
- -
- -
Effective Tax Rate (%)
-2.01
3.29
2.43
3.61
4.32
6.52
7
11.2
9.17
9.57
10.47
9.65
2.77
- -
Profit Margin (%)
163
77
153
170
167
209
361
1,228
1,130
1,324
1,709
1,865
1,749
1,881
Working Capital
- -
- -
- -
- -
- -
93
84
57
51
91
230
482
2,272
2,814
LT Debt
287
236
313
336
368
485
669
1,705
1,867
2,414
3,055
3,534
4,119
3,704
Total Equity
- -
4.92
3.33
4.22
6.42
9.9
11.25
9.84
9.09
9.68
12.23
14.22
- -
- -
Return on Invested Capital (%)
- -
4.9
4.02
5.99
8.46
11.9
12.22
10.03
9.12
10.01
11.36
12.29
- -
- -
Return on Capital (%)
- -
6.64
4.82
6.77
9.01
14.49
14.54
10.47
9.44
12.11
14.84
16.36
3.78
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
919
810
1,198
LT Borrowings
2,241
2,566
2,791
LT Finance Leases
31
29
23
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
294
294
294
Market Capitalization
9,303
8,192
23,254

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
7,503
7,314
7,723
Cash, Cash Equivalents & STI
1,425
984
1,031
Accounts Receivable, Net
2,372
2,257
2,415
Inventories
2,951
3,180
3,439
Total Current Liabilities
5,755
5,301
5,842
Payables & Accruals
- -
- -
- -
ST Debt
919
810
1,198
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.89%
19.52%
16.53%
Free Cash Flow
26.17%
137.17%
570.48%
Net Income, GAAP
40.02%
20.32%
-74.17%
Sales/Revenue/Turnover
27.5%
37.44%
-10.11%
Total Cash Common Dividend
123.68%
130.53%
5.75%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
589
1,264
1,649
1,968
5,469
2025
677
1,340
- -
1,624
4,916
2026
970
1,260
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.09
0.28
0.8
0.69
1.88
2025
0.12
0.21
- -
0.23
0.48
2026
-0.09
-0.08
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.31
0.03
0.02
0.38
2025
0.03
0.32
- -
0.01
0.39
2026
0.07
0.18
- -
- -
- -
Business
Shanghai GenTech Co., Ltd. (688596.SS) provides process critical system solutions to customers in hi-tech and advanced manufacturing industries principally in China. The company manufactures and supplies specialty gases and chemicals, including arsine, phosphine, silane, ammonia, TMA, various gas mixtures, and other electronic materials; process delivery systems; vacuum and exhaust gas treatment systems; life safety and process monitoring systems; clean process material systems; material recovery and recycling systems; new energy-storage mediums; and bioseparation and purification systems, serving integrated circuit (IC), flat panel display, solar photovoltaics, LED lighting, optical fiber manufacturing, and bio-pharmaceutical sectors. It also offers equipment and system integration process services encompassing design, manufacturing, installation, technical support, maintenance, repair, and operation services. Founded in 2009 and headquartered at No. 55 Chunyong Road, Minhang District, Shanghai, China, Shanghai GenTech operates primarily in the domestic market with approximately 1,914 employees. In recent developments, the company signed an equity acquisition intent agreement to acquire a 62.2% stake in Liaoning Hanjing Semiconductor Materials Co., Ltd.; agreed to acquire an additional stake in Hongge Semiconductor Equipment with financing of CNY 335.67 million; and had its convertible bonds issuance project approved by the Shanghai Stock Exchange's Listing Review Committee in January 2025, marking the first such approval on the STAR Market that year.